T1	AdverseReaction 56 67	Bradycardia
T2	AdverseReaction 75 102	atrioventricular conduction
T3	AdverseReaction 160 170	Infections
T4	AdverseReaction 205 215	infections
T5	Factor 197 201	risk
T6	AdverseReaction 422 464	Progressive multifocal leukoencephalopathy
T7	AdverseReaction 466 469	PML
T8	AdverseReaction 552 565	Macular edema
T9	AdverseReaction 769 813	Posterior reversible encephalopathy syndrome
T10	AdverseReaction 815 819	PRES
T11	AdverseReaction 872 908	Decrease in pulmonary function tests
T12	AdverseReaction 969 981	Liver injury
T16	AdverseReaction 1617 1636	heart rate decrease
T17	AdverseReaction 1682 1703	decline in heart rate
T18	AdverseReaction 1882 1901	heart rate decrease
T19	AdverseReaction 1958 1977	heart rate decrease
T20	AdverseReaction 2071 2108	Heart rates below 40 beats per minute
T21	AdverseReaction 2183 2206	symptomatic bradycardia
T22	AdverseReaction 2352 2363	bradycardia
T23	AdverseReaction 2423 2434	hypotension
T24	AdverseReaction 2436 2445	dizziness
T25	AdverseReaction 2447 2454	fatigue
T26	AdverseReaction 2456 2468	palpitations
T27	AdverseReaction 2477 2487	chest pain
T28	AdverseReaction 2593 2615	decrease in heart rate
T29	AdverseReaction 2963 2983	AV conduction delays
T30	Severity 2953 2962	transient
T31	AdverseReaction 3016 3037	first-degree AV block
T32	AdverseReaction 3283 3306	second-degree AV blocks
T33	AdverseReaction 3339 3352	2:1 AV blocks
T34	AdverseReaction 3496 3508	2:1 AV block
T35	AdverseReaction 3599 3622;3639 3652	second degree AV blocks Mobitz Type I
T36	Factor 3626 3633	placebo
T37	AdverseReaction 3705 3729	conduction abnormalities
T38	Severity 3743 3752	transient
T40	AdverseReaction 3965 3986	third-degree AV block
T41	AdverseReaction 4005 4022	junctional escape
T42	AdverseReaction 4155 4163	asystole
T43	Severity 4145 4154	transient
T44	AdverseReaction 4180 4185	death
T45	AdverseReaction 4375 4382	syncope
T46	AdverseReaction 4524 4564	reduction in peripheral lymphocyte count
T47	Severity 4568 4587	20%-30% of baseline
T48	AdverseReaction 4617 4665	sequestration of lymphocytes in lymphoid tissues
T49	Severity 4606 4616	reversible
T50	AdverseReaction 4710 4720	infections
T52	Severity 4727 4734	serious
T53	AdverseReaction 5487 5497	infections
T54	AdverseReaction 5550 5560	bronchitis
T55	AdverseReaction 5562 5575	herpes zoster
T56	AdverseReaction 5577 5586	influenza
T57	AdverseReaction 5588 5597	sinusitis
T58	AdverseReaction 5603 5612	pneumonia
T59	AdverseReaction 5667 5677	infections
T60	Severity 5659 5666	Serious
T61	AdverseReaction 5843 5862	herpetic infections
T62	AdverseReaction 5954 5973	herpetic infections
T63	AdverseReaction 5946 5950	died
T64	AdverseReaction 6004 6009	death
T65	AdverseReaction 6021 6055	disseminated primary herpes zoster
T66	AdverseReaction 6073 6100	herpes simplex encephalitis
T67	Severity 6311 6327	life-threatening
T68	Severity 6302 6309	Serious
T69	AdverseReaction 6338 6367;6387 6397	disseminated varicella zoster infections
T70	AdverseReaction 6372 6397	herpes simplex infections
T71	AdverseReaction 6418 6430	encephalitis
T72	AdverseReaction 6435 6453	multiorgan failure
T73	AdverseReaction 6543 6548	fatal
T74	AdverseReaction 6763 6786	Cryptococcal infections
T75	AdverseReaction 6807 6830	cryptococcal meningitis
T76	AdverseReaction 7480 7497	immunosuppression
T77	Factor 7472 7476	risk
T78	AdverseReaction 8359 8401	progressive multifocal leukoencephalopathy
T79	AdverseReaction 8403 8406	PML
T80	AdverseReaction 8431 8434	PML
T81	Factor 8422 8430	probable
T82	AdverseReaction 8740 8743	PML
T83	AdverseReaction 8516 8519	PML
T84	AdverseReaction 8526 8568	opportunistic viral infection of the brain
T85	AdverseReaction 8583 8591	JC virus
T86	AdverseReaction 8593 8596	JCV
T87	AdverseReaction 8690 8695	death
T88	AdverseReaction 8706 8716	disability
T89	AdverseReaction 8831 8834	PML
T90	Factor 8822 8830	probable
T91	AdverseReaction 8909 8912	PML
T92	Factor 8900 8908	probable
T93	AdverseReaction 8960 8963;8968 8978	JCV in the CSF
T94	AdverseReaction 9036 9039	PML
T95	Negation 8986 8993	absence
T96	AdverseReaction 9119 9144	compromised immune system
T97	AdverseReaction 9243 9246	PML
T98	Negation 9195 9206	natalizumab
T99	AdverseReaction 9558 9561	PML
T100	AdverseReaction 9616 9660	progressive weakness on one side of the body
T101	AdverseReaction 9664 9683	clumsiness of limbs
T102	AdverseReaction 9685 9706	disturbance of vision
T103	AdverseReaction 9712 9731	changes in thinking
T104	AdverseReaction 9712 9722;9733 9739	changes in memory
T105	AdverseReaction 9712 9722;9745 9756	changes in orientation
T106	AdverseReaction 9768 9777	confusion
T107	AdverseReaction 9782 9801	personality changes
T108	AdverseReaction 9873 9886	macular edema
T109	AdverseReaction 10172 10185	macular edema
T110	Factor 10164 10168	risk
T111	AdverseReaction 10336 10349	macular edema
T112	AdverseReaction 10366 10381	visual symptoms
T113	AdverseReaction 10557 10570	Macular edema
T116	AdverseReaction 10837 10850	macular edema
T117	AdverseReaction 10860 10874	blurred vision
T118	AdverseReaction 10879 10902	decreased visual acuity
T119	AdverseReaction 11006 11019	Macular edema
T120	AdverseReaction 10950 10963	macular edema
T121	AdverseReaction 10989 11004	visual symptoms
T122	Negation 10986 10988	no
T123	AdverseReaction 11144 11162	visual acuity loss
T124	AdverseReaction 11188 11201	macular edema
T125	AdverseReaction 11203 11216	Macular edema
T126	AdverseReaction 11406 11419	macular edema
T127	AdverseReaction 11841 11854	macular edema
T128	Factor 11833 11837	risk
T129	AdverseReaction 11896 11909	macular edema
T130	AdverseReaction 12054 12067	macular edema
T131	AdverseReaction 12578 12622	posterior reversible encephalopathy syndrome
T132	AdverseReaction 12624 12628	PRES
T133	AdverseReaction 12720 12728	headache
T134	AdverseReaction 12730 12751	altered mental status
T135	AdverseReaction 12753 12772	visual disturbances
T136	AdverseReaction 12778 12785	seizure
T137	AdverseReaction 12799 12803	PRES
T138	AdverseReaction 12847 12862	ischemic stroke
T139	AdverseReaction 12866 12885	cerebral hemorrhage
T140	Factor 12831 12834	may
T141	AdverseReaction 13075 13127	reductions in forced expiratory volume over 1 second
T142	AdverseReaction 13075 13088;13139 13182	reductions in diffusion lung capacity for carbon monoxide
T143	AdverseReaction 13326 13335;13385 13393	reduction for FEV1
T145	AdverseReaction 13487 13491;13497 13506	DLCO reduction
T144	AdverseReaction 13645 13660	changes in FEV1
T146	Severity 13674 13684	reversible
T147	AdverseReaction 13790 13806	decrease of DLCO
T148	AdverseReaction 13868 13875	dyspnea
T149	AdverseReaction 14031 14038	dyspnea
T150	AdverseReaction 14348 14375	Elevations of liver enzymes
T151	AdverseReaction 14596 14628	elevation of liver transaminases
T152	Severity 14632 14670	3-fold the upper limit of normal (ULN)
T153	AdverseReaction 15146 15175	liver transaminase elevations
T154	AdverseReaction 15584 15606	elevated liver enzymes
T155	Animal 15913 15919	animal
T156	AdverseReaction 15947 15957	fetal harm
T157	AdverseReaction 16308 16316;16357 16374	increase systolic pressure
T158	Severity 16347 16353	3 mmHg
T159	AdverseReaction 16308 16316;16404 16422	increase diastolic pressure
T160	Severity 16394 16400	2 mmHg
T161	AdverseReaction 16533 16545	Hypertension
T162	AdverseReaction 16870 16897	decreased lymphocyte counts
T163	AdverseReaction 17287 17312	immunosuppressant effects
T164	Factor 17270 17274	risk
T13	AdverseReaction 3297 3306;3308 3322	AV blocks Mobitz Types I
T14	AdverseReaction 3297 3306;3324 3334	AV blocks Wenckebach
T15	Factor 8603 8612	typically
T165	Factor 8673 8680	usually
T166	Factor 9525 9532	Typical
T167	Factor 9865 9869	risk
T114	AdverseReaction 13075 13088;13184 13188	reductions in DLCO
T115	AdverseReaction 13075 13088;13129 13133	reductions in FEV1
T168	Severity 13437 13441	2.8%
T169	Severity 13595 13599	3.3%
T170	Factor 14376 14379	may
T171	Factor 15565 15569	risk
T39	AdverseReaction 872 883;910 913	Decrease in PFT
T172	Factor 4702 4706	risk
T51	Severity 8699 8705	severe
T173	Severity 12713 12719	severe
T174	AdverseReaction 3991 3999	AV block
E1	AdverseReaction:T1
E2	AdverseReaction:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4 Hypothetical:E5
E5	Factor:T5
E6	AdverseReaction:T6
E7	AdverseReaction:T7
E8	AdverseReaction:T8
E9	AdverseReaction:T9
E10	AdverseReaction:T10
E11	AdverseReaction:T11
E12	AdverseReaction:T12
E16	AdverseReaction:T16
E17	AdverseReaction:T17
E18	AdverseReaction:T18
E19	AdverseReaction:T19
E20	AdverseReaction:T20
E21	AdverseReaction:T21
E22	AdverseReaction:T22
E23	AdverseReaction:T23
E24	AdverseReaction:T24
E25	AdverseReaction:T25
E26	AdverseReaction:T26
E27	AdverseReaction:T27
E28	AdverseReaction:T28
E29	AdverseReaction:T29 Effect:E30
E30	Severity:T30
E31	AdverseReaction:T31
E32	AdverseReaction:T32
E33	AdverseReaction:T33
E34	AdverseReaction:T34
E35	AdverseReaction:T35 Negated:E36
E36	Factor:T36
E37	AdverseReaction:T37 Effect:E38
E38	Severity:T38
E40	AdverseReaction:T40
E41	AdverseReaction:T41
E42	AdverseReaction:T42 Effect:E43
E43	Severity:T43
E44	AdverseReaction:T44
E45	AdverseReaction:T45
E46	AdverseReaction:T46 Effect:E47
E47	Severity:T47
E48	AdverseReaction:T48 Effect:E49
E49	Severity:T49
E50	AdverseReaction:T50 Hypothetical:E173
E52	AdverseReaction:T50 Effect:E53 Hypothetical:E173
E53	Severity:T52
E54	AdverseReaction:T53
E55	AdverseReaction:T54
E56	AdverseReaction:T55
E57	AdverseReaction:T56
E58	AdverseReaction:T57
E59	AdverseReaction:T58
E60	AdverseReaction:T59 Effect:E61
E61	Severity:T60
E62	AdverseReaction:T61
E63	AdverseReaction:T62
E64	AdverseReaction:T63
E65	AdverseReaction:T64
E66	AdverseReaction:T65
E67	AdverseReaction:T66
E68	Severity:T67
E69	Severity:T68
E70	AdverseReaction:T69 Effect:E69 Effect2:E68
E71	AdverseReaction:T70 Effect:E68 Effect2:E69
E72	AdverseReaction:T71
E73	AdverseReaction:T72
E74	AdverseReaction:T73
E75	AdverseReaction:T74
E76	AdverseReaction:T75
E77	AdverseReaction:T76 Hypothetical:E78
E78	Factor:T77
E79	AdverseReaction:T78
E80	AdverseReaction:T79
E81	AdverseReaction:T80 Hypothetical:E82
E82	Factor:T81
E83	AdverseReaction:T82
E84	AdverseReaction:T83 Hypothetical:E15
E85	AdverseReaction:T84 Hypothetical:E15
E86	AdverseReaction:T85 Hypothetical:E15
E87	AdverseReaction:T86
E88	AdverseReaction:T87 Hypothetical:E166
E89	AdverseReaction:T88 Hypothetical:E166 Effect:E51
E90	AdverseReaction:T89 Hypothetical:E91
E91	Factor:T90
E92	AdverseReaction:T91 Hypothetical:E93
E93	Factor:T92
E94	AdverseReaction:T93
E95	AdverseReaction:T94 Negated:E96
E96	Negation:T95
E97	AdverseReaction:T96
E98	AdverseReaction:T97 Negated:E99
E99	Negation:T98
E100	AdverseReaction:T99 Hypothetical:E167
E101	AdverseReaction:T100 Hypothetical:E167
E102	AdverseReaction:T101 Hypothetical:E167
E103	AdverseReaction:T102 Hypothetical:E167
E104	AdverseReaction:T103 Hypothetical:E167
E105	AdverseReaction:T104 Hypothetical:E167
E106	AdverseReaction:T105 Hypothetical:E167
E107	AdverseReaction:T106 Hypothetical:E167
E108	AdverseReaction:T107 Hypothetical:E167
E109	AdverseReaction:T108 Hypothetical:E168
E110	AdverseReaction:T109 Hypothetical:E111
E111	Factor:T110
E112	AdverseReaction:T111
E113	AdverseReaction:T112
E114	AdverseReaction:T113
E117	AdverseReaction:T116
E118	AdverseReaction:T117
E119	AdverseReaction:T118
E120	AdverseReaction:T119
E121	AdverseReaction:T120
E122	AdverseReaction:T121 Negated:E123
E123	Negation:T122
E124	AdverseReaction:T123
E125	AdverseReaction:T124
E126	AdverseReaction:T125
E127	AdverseReaction:T126
E128	AdverseReaction:T127 Hypothetical:E129
E129	Factor:T128
E130	AdverseReaction:T129
E131	AdverseReaction:T130
E132	AdverseReaction:T131
E133	AdverseReaction:T132
E134	AdverseReaction:T133 Effect:E174
E135	AdverseReaction:T134
E136	AdverseReaction:T135
E137	AdverseReaction:T136
E138	AdverseReaction:T137
E139	AdverseReaction:T138 Hypothetical:E141
E140	AdverseReaction:T139 Hypothetical:E141
E141	Factor:T140
E142	AdverseReaction:T141
E143	AdverseReaction:T142
E144	AdverseReaction:T143 Effect:E169
E146	AdverseReaction:T145 Effect:E170
E145	AdverseReaction:T144 Effect:E147
E147	Severity:T146
E148	AdverseReaction:T147
E149	AdverseReaction:T148
E150	AdverseReaction:T149
E151	AdverseReaction:T150 Hypothetical:E171
E152	AdverseReaction:T151 Effect:E153
E153	Severity:T152
E154	AdverseReaction:T153
E155	AdverseReaction:T154 Hypothetical:E172
E156	Animal:T155
E157	AdverseReaction:T156 Hypothetical:E156
E158	AdverseReaction:T157 Effect:E159
E159	Severity:T158
E160	AdverseReaction:T159 Effect:E161
E161	Severity:T160
E162	AdverseReaction:T161
E163	AdverseReaction:T162
E164	AdverseReaction:T163 Hypothetical:E165
E165	Factor:T164
E13	AdverseReaction:T13
E14	AdverseReaction:T14
E15	Factor:T15
E166	Factor:T165
E167	Factor:T166
E168	Factor:T167
E115	AdverseReaction:T114
E116	AdverseReaction:T115
E169	Severity:T168
E170	Severity:T169
E171	Factor:T170
E172	Factor:T171
E39	AdverseReaction:T39
E173	Factor:T172
E51	Severity:T51
E174	Severity:T173
E175	AdverseReaction:T174
A1	CUI E1 C0428977
A2	UMLS-Preferred-Name E1 Bradycardia
A3	MEDDRA-PT E1 Bradycardia
A4	MEDDRA-PT-ID E1 10006093
A5	CUI E2 C0085614
A6	UMLS-Preferred-Name E2 First degree atrioventricular block
A7	MEDDRA-PT E2 Atrioventricular block first degree
A8	MEDDRA-PT-ID E2 10003674
A9	LLT E2 Atrioventricular conduction time prolonged
A10	LLT-ID E2 10003681
A11	CUI E3 C3714514
A12	UMLS-Preferred-Name E3 Infection
A13	MEDDRA-PT E3 Infection
A14	MEDDRA-PT-ID E3 10021789
A15	CUI E4 C3714514
A16	UMLS-Preferred-Name E4 Infection
A17	MEDDRA-PT E4 Infection
A18	MEDDRA-PT-ID E4 10021789
A19	CUI E6 C0023524
A20	UMLS-Preferred-Name E6 Leukoencephalopathy, Progressive Multifocal
A21	MEDDRA-PT E6 Progressive multifocal leukoencephalopathy
A22	MEDDRA-PT-ID E6 10036807
A23	CUI E7 C0023524
A24	UMLS-Preferred-Name E7 Leukoencephalopathy, Progressive Multifocal
A25	MEDDRA-PT E7 Progressive multifocal leukoencephalopathy
A26	MEDDRA-PT-ID E7 10036807
A27	CUI E8 C0271051
A28	UMLS-Preferred-Name E8 Macular retinal edema
A29	MEDDRA-PT E8 Macular oedema
A30	MEDDRA-PT-ID E8 10025415
A31	LLT E8 Macular edema
A32	LLT-ID E8 10054467
A33	CUI E9 C3160858
A34	UMLS-Preferred-Name E9 Posterior reversible encephalopathy syndrome
A35	MEDDRA-PT E9 Posterior reversible encephalopathy syndrome
A36	MEDDRA-PT-ID E9 10071066
A37	CUI E10 C3160858
A38	UMLS-Preferred-Name E10 Posterior reversible encephalopathy syndrome
A39	MEDDRA-PT E10 Posterior reversible encephalopathy syndrome
A40	MEDDRA-PT-ID E10 10071066
A41	CUI E11 C0855775
A42	UMLS-Preferred-Name E11 Pulmonary function test decreased
A43	MEDDRA-PT E11 Pulmonary function test decreased
A44	MEDDRA-PT-ID E11 10061922
A45	CUI E12 C0160390
A46	UMLS-Preferred-Name E12 Injury of liver
A47	MEDDRA-PT E12 Liver injury
A48	MEDDRA-PT-ID E12 10067125
A49	CUI E16 C2230138
A50	UMLS-Preferred-Name E16 Pulse slow (finding)
A51	MEDDRA-PT E16 Heart rate decreased
A52	MEDDRA-PT-ID E16 10019301
A53	CUI E17 C2230138
A54	UMLS-Preferred-Name E17 Pulse slow (finding)
A55	MEDDRA-PT E17 Heart rate decreased
A56	MEDDRA-PT-ID E17 10019301
A57	CUI E18 C2230138
A58	UMLS-Preferred-Name E18 Pulse slow (finding)
A59	MEDDRA-PT E18 Heart rate decreased
A60	MEDDRA-PT-ID E18 10019301
A61	CUI E19 C2230138
A62	UMLS-Preferred-Name E19 Pulse slow (finding)
A63	MEDDRA-PT E19 Heart rate decreased
A64	MEDDRA-PT-ID E19 10019301
A65	CUI E20 C2230138
A66	UMLS-Preferred-Name E20 Pulse slow (finding)
A67	MEDDRA-PT E20 Heart rate decreased
A68	MEDDRA-PT-ID E20 10019301
A69	CUI E21 C0741627
A70	UMLS-Preferred-Name E21 BRADYCARDIA SYMPTOMATIC
A71	MEDDRA-PT E21 Bradycardia
A72	MEDDRA-PT-ID E21 10006093
A73	CUI E22 C0428977
A74	UMLS-Preferred-Name E22 Bradycardia
A75	MEDDRA-PT E22 Bradycardia
A76	MEDDRA-PT-ID E22 10006093
A77	CUI E23 C0020649
A78	UMLS-Preferred-Name E23 Hypotension
A79	MEDDRA-PT E23 Hypotension
A80	MEDDRA-PT-ID E23 10021097
A81	CUI E24 C0012833
A82	UMLS-Preferred-Name E24 Dizziness
A83	MEDDRA-PT E24 Dizziness
A84	MEDDRA-PT-ID E24 10013573
A85	CUI E25 C0015672
A86	UMLS-Preferred-Name E25 Fatigue
A87	MEDDRA-PT E25 Fatigue
A88	MEDDRA-PT-ID E25 10016256
A89	CUI E26 C0030252
A90	UMLS-Preferred-Name E26 Palpitations
A91	MEDDRA-PT E26 Palpitations
A92	MEDDRA-PT-ID E26 10033557
A93	CUI E27 C0008031
A94	UMLS-Preferred-Name E27 Chest Pain
A95	MEDDRA-PT E27 Chest pain
A96	MEDDRA-PT-ID E27 10008479
A97	CUI E28 C2230138
A98	UMLS-Preferred-Name E28 Pulse slow (finding)
A99	MEDDRA-PT E28 Heart rate decreased
A100	MEDDRA-PT-ID E28 10019301
A101	CUI E29 C0085614
A102	UMLS-Preferred-Name E29 First degree atrioventricular block
A103	MEDDRA-PT E29 Atrioventricular block first degree
A104	MEDDRA-PT-ID E29 10003674
A105	LLT E29 Atrioventricular conduction time prolonged
A106	LLT-ID E29 10003681
A107	CUI E31 C0085614
A108	UMLS-Preferred-Name E31 First degree atrioventricular block
A109	MEDDRA-PT E31 Atrioventricular block first degree
A110	MEDDRA-PT-ID E31 10003674
A111	LLT E31 AV block first degree
A112	LLT-ID E31 10003850
A113	CUI E32 C0264906
A114	UMLS-Preferred-Name E32 Second degree atrioventricular block
A115	MEDDRA-PT E32 Atrioventricular block second degree
A116	MEDDRA-PT-ID E32 10003677
A117	LLT E32 AV block second degree
A118	LLT-ID E32 10003851
A119	CUI E33 C2346542
A120	UMLS-Preferred-Name E33 2:1 Atrioventricular Block by ECG Finding
A121	MEDDRA-PT E33 Atrioventricular block
A122	MEDDRA-PT-ID E33 10003671
A123	LLT E33 AV block
A124	LLT-ID E33 10003846
A125	CUI E34 C2346542
A126	UMLS-Preferred-Name E34 2:1 Atrioventricular Block by ECG Finding
A127	MEDDRA-PT E34 Atrioventricular block
A128	MEDDRA-PT-ID E34 10003671
A129	LLT E34 AV block
A130	LLT-ID E34 10003846
A131	CUI E35 C0264907
A132	UMLS-Preferred-Name E35 Mobitz type I incomplete atrioventricular block
A133	MEDDRA-PT E35 Atrioventricular block second degree
A134	MEDDRA-PT-ID E35 10003677
A135	LLT E35 Mobitz type I
A136	LLT-ID E35 10027787
A137	CUI E37 C0232219
A138	UMLS-Preferred-Name E37 Abnormal cardiac conduction
A139	MEDDRA-PT E37 Conduction disorder
A140	MEDDRA-PT-ID E37 10010276
A141	LLT E37 Defect conduction (NOS)
A142	LLT-ID E37 10012117
A143	CUI E40 C0151517
A144	UMLS-Preferred-Name E40 Complete atrioventricular block
A145	MEDDRA-PT E40 Atrioventricular block complete
A146	MEDDRA-PT-ID E40 10003673
A147	LLT E40 Third degree AV block
A148	LLT-ID E40 10043440
A149	CUI E41 C0232210
A150	UMLS-Preferred-Name E41 Junctional escape beats
A151	MEDDRA-PT E41 Nodal rhythm
A152	MEDDRA-PT-ID E41 10029470
A153	LLT E41 Atrioventricular junctional escape rhythm
A154	LLT-ID E41 10057524
A155	CUI E42 C0018790
A156	UMLS-Preferred-Name E42 Cardiac Arrest
A157	MEDDRA-PT E42 Cardiac arrest
A158	MEDDRA-PT-ID E42 10007515
A159	LLT E42 Asystole
A160	LLT-ID E42 10003586
A161	CUI E44 C1306577
A162	UMLS-Preferred-Name E44 Death (finding)
A163	MEDDRA-PT E44 Death
A164	MEDDRA-PT-ID E44 10011906
A165	CUI E45 C0039070
A166	UMLS-Preferred-Name E45 Syncope
A167	MEDDRA-PT E45 Syncope
A168	MEDDRA-PT-ID E45 10042772
A169	CUI E46 C0853986
A170	UMLS-Preferred-Name E46 Lymphocyte count decreased
A171	MEDDRA-PT E46 Lymphocyte count decreased
A172	MEDDRA-PT-ID E46 10025256
A173	flag E48 unmapped
A174	CUI E50 C3714514
A175	UMLS-Preferred-Name E50 Infection
A176	MEDDRA-PT E50 Infection
A177	MEDDRA-PT-ID E50 10021789
A178	CUI E54 C3714514
A179	UMLS-Preferred-Name E54 Infection
A180	MEDDRA-PT E54 Infection
A181	MEDDRA-PT-ID E54 10021789
A182	CUI E55 C0006277
A183	UMLS-Preferred-Name E55 Bronchitis
A184	MEDDRA-PT E55 Bronchitis
A185	MEDDRA-PT-ID E55 10006451
A186	CUI E56 C0019360
A187	UMLS-Preferred-Name E56 Herpes zoster disease
A188	MEDDRA-PT E56 Herpes zoster
A189	MEDDRA-PT-ID E56 10019974
A190	CUI E57 C0021400
A191	UMLS-Preferred-Name E57 Influenza
A192	MEDDRA-PT E57 Influenza
A193	MEDDRA-PT-ID E57 10022000
A194	CUI E58 C0037199
A195	UMLS-Preferred-Name E58 Sinusitis
A196	MEDDRA-PT E58 Sinusitis
A197	MEDDRA-PT-ID E58 10040753
A198	CUI E59 C0032285
A199	UMLS-Preferred-Name E59 Pneumonia
A200	MEDDRA-PT E59 Pneumonia
A201	MEDDRA-PT-ID E59 10035664
A202	CUI E60 C3714514
A203	UMLS-Preferred-Name E60 Infection
A204	MEDDRA-PT E60 Infection
A205	MEDDRA-PT-ID E60 10021789
A206	CUI E62 C0019372
A207	UMLS-Preferred-Name E62 Herpesviridae Infections
A208	MEDDRA-PT E62 Herpes virus infection
A209	MEDDRA-PT-ID E62 10019973
A210	CUI E63 C0019372
A211	UMLS-Preferred-Name E63 Herpesviridae Infections
A212	MEDDRA-PT E63 Herpes virus infection
A213	MEDDRA-PT-ID E63 10019973
A214	CUI E64 C1306577
A215	UMLS-Preferred-Name E64 Death (finding)
A216	MEDDRA-PT E64 Death
A217	MEDDRA-PT-ID E64 10011906
A218	CUI E65 C1306577
A219	UMLS-Preferred-Name E65 Death (finding)
A220	MEDDRA-PT E65 Death
A221	MEDDRA-PT-ID E65 10011906
A222	CUI E66 C0276248
A223	UMLS-Preferred-Name E66 Disseminated herpes zoster
A224	MEDDRA-PT E66 Herpes zoster disseminated
A225	MEDDRA-PT-ID E66 10065038
A226	CUI E67 C0276226
A227	UMLS-Preferred-Name E67 Herpes encephalitis
A228	MEDDRA-PT E67 Herpes simplex encephalitis
A229	MEDDRA-PT-ID E67 10019953
A230	flag E70 unmapped
A231	CUI E70 C0750128
A232	UMLS-Preferred-Name E70 VARICELLA ZOSTER DISSEMINATED
A233	CUI E71 C0019348
A234	UMLS-Preferred-Name E71 Herpes Simplex Infections
A235	MEDDRA-PT E71 Herpes simplex
A236	MEDDRA-PT-ID E71 10019948
A237	CUI E72 C0014038
A238	UMLS-Preferred-Name E72 Encephalitis
A239	MEDDRA-PT E72 Encephalitis
A240	MEDDRA-PT-ID E72 10014581
A241	CUI E73 C0026766
A242	UMLS-Preferred-Name E73 Multiple Organ Failure
A243	MEDDRA-PT E73 Multi-organ failure
A244	MEDDRA-PT-ID E73 10028154
A245	LLT E73 Multiorgan failure
A246	LLT-ID E73 10028162
A247	CUI E74 C1306577
A248	UMLS-Preferred-Name E74 Death (finding)
A249	MEDDRA-PT E74 Death
A250	MEDDRA-PT-ID E74 10011906
A251	flag E75 HLT
A252	CUI E75 C0740272
A253	UMLS-Preferred-Name E75 Cryptococcal infections
A254	MEDDRA-PT E75 Cryptococcal infections
A255	MEDDRA-PT-ID E75 10011486
A256	CUI E76 C0085436
A257	UMLS-Preferred-Name E76 Meningitis, Cryptococcal
A258	MEDDRA-PT E76 Meningitis cryptococcal
A259	MEDDRA-PT-ID E76 10027209
A260	LLT E76 Cryptococcal meningitis
A261	LLT-ID E76 10011487
A262	CUI E77 C1373218
A263	UMLS-Preferred-Name E77 Decreased Immunologic Activity [PE]
A264	MEDDRA-PT E77 Immunosuppression
A265	MEDDRA-PT-ID E77 10062016
A266	CUI E79 C0023524
A267	UMLS-Preferred-Name E79 Leukoencephalopathy, Progressive Multifocal
A268	MEDDRA-PT E79 Progressive multifocal leukoencephalopathy
A269	MEDDRA-PT-ID E79 10036807
A270	CUI E80 C0023524
A271	UMLS-Preferred-Name E80 Leukoencephalopathy, Progressive Multifocal
A272	MEDDRA-PT E80 Progressive multifocal leukoencephalopathy
A273	MEDDRA-PT-ID E80 10036807
A274	CUI E81 C0023524
A275	UMLS-Preferred-Name E81 Leukoencephalopathy, Progressive Multifocal
A276	MEDDRA-PT E81 Progressive multifocal leukoencephalopathy
A277	MEDDRA-PT-ID E81 10036807
A278	CUI E83 C0023524
A279	UMLS-Preferred-Name E83 Leukoencephalopathy, Progressive Multifocal
A280	MEDDRA-PT E83 Progressive multifocal leukoencephalopathy
A281	MEDDRA-PT-ID E83 10036807
A282	CUI E84 C0023524
A283	UMLS-Preferred-Name E84 Leukoencephalopathy, Progressive Multifocal
A284	MEDDRA-PT E84 Progressive multifocal leukoencephalopathy
A285	MEDDRA-PT-ID E84 10036807
A286	flag E85 duplicate
A287	CUI E85 C0348165
A288	UMLS-Preferred-Name E85 Central Nervous System Viral Diseases
A289	MEDDRA-PT E85 Central nervous system viral infection
A290	MEDDRA-PT-ID E85 10061037
A291	CUI E86 C0857836
A292	UMLS-Preferred-Name E86 JC virus infection
A293	MEDDRA-PT E86 JC virus infection
A294	MEDDRA-PT-ID E86 10023163
A295	CUI E87 C0857836
A296	UMLS-Preferred-Name E87 JC virus infection
A297	MEDDRA-PT E87 JC virus infection
A298	MEDDRA-PT-ID E87 10023163
A299	CUI E88 C1306577
A300	UMLS-Preferred-Name E88 Death (finding)
A301	MEDDRA-PT E88 Death
A302	MEDDRA-PT-ID E88 10011906
A303	CUI E89 C0231170
A304	UMLS-Preferred-Name E89 Disability
A305	MEDDRA-PT E89 Disability
A306	MEDDRA-PT-ID E89 10013050
A307	CUI E90 C0023524
A308	UMLS-Preferred-Name E90 Leukoencephalopathy, Progressive Multifocal
A309	MEDDRA-PT E90 Progressive multifocal leukoencephalopathy
A310	MEDDRA-PT-ID E90 10036807
A311	CUI E92 C0023524
A312	UMLS-Preferred-Name E92 Leukoencephalopathy, Progressive Multifocal
A313	MEDDRA-PT E92 Progressive multifocal leukoencephalopathy
A314	MEDDRA-PT-ID E92 10036807
A315	flag E94 underspecified
A316	CUI E94 C0857836
A317	UMLS-Preferred-Name E94 JC virus infection
A318	MEDDRA-PT E94 JC virus infection
A319	MEDDRA-PT-ID E94 10023163
A320	CUI E95 C0023524
A321	UMLS-Preferred-Name E95 Leukoencephalopathy, Progressive Multifocal
A322	MEDDRA-PT E95 Progressive multifocal leukoencephalopathy
A323	MEDDRA-PT-ID E95 10036807
A324	CUI E97 C0085393
A325	UMLS-Preferred-Name E97 Immunocompromised Host
A326	MEDDRA-PT E97 Immunodeficiency
A327	MEDDRA-PT-ID E97 10061598
A328	CUI E98 C0023524
A329	UMLS-Preferred-Name E98 Leukoencephalopathy, Progressive Multifocal
A330	MEDDRA-PT E98 Progressive multifocal leukoencephalopathy
A331	MEDDRA-PT-ID E98 10036807
A332	CUI E100 C0023524
A333	UMLS-Preferred-Name E100 Leukoencephalopathy, Progressive Multifocal
A334	MEDDRA-PT E100 Progressive multifocal leukoencephalopathy
A335	MEDDRA-PT-ID E100 10036807
A336	CUI E101 C0240421
A337	UMLS-Preferred-Name E101 Progressive muscle weakness
A338	MEDDRA-PT E101 Muscular weakness
A339	MEDDRA-PT-ID E101 10028372
A340	LLT E101 Muscle weakness
A341	LLT-ID E101 10028350
A342	CUI E102 C0233844
A343	UMLS-Preferred-Name E102 Clumsiness
A344	MEDDRA-PT E102 Clumsiness
A345	MEDDRA-PT-ID E102 10009696
A346	CUI E103 C0547030
A347	UMLS-Preferred-Name E103 Visual disturbance
A348	MEDDRA-PT E103 Visual impairment
A349	MEDDRA-PT-ID E103 10047571
A350	LLT E103 Visual disturbances
A351	LLT-ID E103 10047545
A352	CUI E104 C0233632
A353	UMLS-Preferred-Name E104 Disturbance in thinking
A354	MEDDRA-PT E104 Thinking abnormal
A355	MEDDRA-PT-ID E104 10043431
A356	CUI E105 C1822023
A357	UMLS-Preferred-Name E105 Memory changes
A358	MEDDRA-PT E105 Memory impairment
A359	MEDDRA-PT-ID E105 10027175
A360	LLT E105 Memory disturbance
A361	LLT-ID E105 10027172
A362	CUI E106 C0233407
A363	UMLS-Preferred-Name E106 Disorientation
A364	MEDDRA-PT E106 Disorientation
A365	MEDDRA-PT-ID E106 10013395
A366	LLT E106 Orientation disturbed
A367	LLT-ID E106 10031087
A368	CUI E107 C0009676
A369	UMLS-Preferred-Name E107 Confusion
A370	MEDDRA-PT E107 Confusional state
A371	MEDDRA-PT-ID E107 10010305
A372	LLT E107 Confusion
A373	LLT-ID E107 10010300
A374	CUI E108 C0240735
A375	UMLS-Preferred-Name E108 Personality change
A376	MEDDRA-PT E108 Personality change
A377	MEDDRA-PT-ID E108 10034719
A378	CUI E109 C0271051
A379	UMLS-Preferred-Name E109 Macular retinal edema
A380	MEDDRA-PT E109 Macular oedema
A381	MEDDRA-PT-ID E109 10025415
A382	LLT E109 Macular edema
A383	LLT-ID E109 10054467
A384	CUI E110 C0271051
A385	UMLS-Preferred-Name E110 Macular retinal edema
A386	MEDDRA-PT E110 Macular oedema
A387	MEDDRA-PT-ID E110 10025415
A388	LLT E110 Macular edema
A389	LLT-ID E110 10054467
A390	CUI E112 C0271051
A391	UMLS-Preferred-Name E112 Macular retinal edema
A392	MEDDRA-PT E112 Macular oedema
A393	MEDDRA-PT-ID E112 10025415
A394	LLT E112 Macular edema
A395	LLT-ID E112 10054467
A396	CUI E113 C0422943
A397	UMLS-Preferred-Name E113 Visual symptoms
A398	MEDDRA-PT E113 Visual impairment
A399	MEDDRA-PT-ID E113 10047571
A400	LLT E113 Abnormal vision
A401	LLT-ID E113 10000186
A402	CUI E114 C0271051
A403	UMLS-Preferred-Name E114 Macular retinal edema
A404	MEDDRA-PT E114 Macular oedema
A405	MEDDRA-PT-ID E114 10025415
A406	LLT E114 Macular edema
A407	LLT-ID E114 10054467
A408	CUI E117 C0271051
A409	UMLS-Preferred-Name E117 Macular retinal edema
A410	MEDDRA-PT E117 Macular oedema
A411	MEDDRA-PT-ID E117 10025415
A412	LLT E117 Macular edema
A413	LLT-ID E117 10054467
A414	CUI E118 C0344232
A415	UMLS-Preferred-Name E118 Blurred vision
A416	MEDDRA-PT E118 Vision blurred
A417	MEDDRA-PT-ID E118 10047513
A418	LLT E118 Blurred vision
A419	LLT-ID E118 10005886
A420	CUI E119 C0234632
A421	UMLS-Preferred-Name E119 Reduced visual acuity
A422	MEDDRA-PT E119 Visual acuity reduced
A423	MEDDRA-PT-ID E119 10047531
A424	LLT E119 Visual acuity decreased
A425	LLT-ID E119 10049061
A426	CUI E120 C0271051
A427	UMLS-Preferred-Name E120 Macular retinal edema
A428	MEDDRA-PT E120 Macular oedema
A429	MEDDRA-PT-ID E120 10025415
A430	LLT E120 Macular edema
A431	LLT-ID E120 10054467
A432	CUI E121 C0271051
A433	UMLS-Preferred-Name E121 Macular retinal edema
A434	MEDDRA-PT E121 Macular oedema
A435	MEDDRA-PT-ID E121 10025415
A436	LLT E121 Macular edema
A437	LLT-ID E121 10054467
A438	CUI E122 C0422943
A439	UMLS-Preferred-Name E122 Visual symptoms
A440	MEDDRA-PT E122 Visual impairment
A441	MEDDRA-PT-ID E122 10047571
A442	LLT E122 Abnormal vision
A443	LLT-ID E122 10000186
A444	CUI E124 C0234632
A445	UMLS-Preferred-Name E124 Reduced visual acuity
A446	MEDDRA-PT E124 Visual acuity reduced
A447	MEDDRA-PT-ID E124 10047531
A448	LLT E124 Visual acuity lost
A449	LLT-ID E124 10047530
A450	CUI E125 C0271051
A451	UMLS-Preferred-Name E125 Macular retinal edema
A452	MEDDRA-PT E125 Macular oedema
A453	MEDDRA-PT-ID E125 10025415
A454	LLT E125 Macular edema
A455	LLT-ID E125 10054467
A456	CUI E126 C0271051
A457	UMLS-Preferred-Name E126 Macular retinal edema
A458	MEDDRA-PT E126 Macular oedema
A459	MEDDRA-PT-ID E126 10025415
A460	LLT E126 Macular edema
A461	LLT-ID E126 10054467
A462	CUI E127 C0271051
A463	UMLS-Preferred-Name E127 Macular retinal edema
A464	MEDDRA-PT E127 Macular oedema
A465	MEDDRA-PT-ID E127 10025415
A466	LLT E127 Macular edema
A467	LLT-ID E127 10054467
A468	CUI E128 C0271051
A469	UMLS-Preferred-Name E128 Macular retinal edema
A470	MEDDRA-PT E128 Macular oedema
A471	MEDDRA-PT-ID E128 10025415
A472	LLT E128 Macular edema
A473	LLT-ID E128 10054467
A474	CUI E130 C0271051
A475	UMLS-Preferred-Name E130 Macular retinal edema
A476	MEDDRA-PT E130 Macular oedema
A477	MEDDRA-PT-ID E130 10025415
A478	LLT E130 Macular edema
A479	LLT-ID E130 10054467
A480	CUI E131 C0271051
A481	UMLS-Preferred-Name E131 Macular retinal edema
A482	MEDDRA-PT E131 Macular oedema
A483	MEDDRA-PT-ID E131 10025415
A484	LLT E131 Macular edema
A485	LLT-ID E131 10054467
A486	CUI E132 C3160858
A487	UMLS-Preferred-Name E132 Posterior reversible encephalopathy syndrome
A488	MEDDRA-PT E132 Posterior reversible encephalopathy syndrome
A489	MEDDRA-PT-ID E132 10071066
A490	CUI E133 C3160858
A491	UMLS-Preferred-Name E133 Posterior reversible encephalopathy syndrome
A492	MEDDRA-PT E133 Posterior reversible encephalopathy syndrome
A493	MEDDRA-PT-ID E133 10071066
A494	CUI E134 C0018681
A495	UMLS-Preferred-Name E134 Headache
A496	MEDDRA-PT E134 Headache
A497	MEDDRA-PT-ID E134 10019211
A498	CUI E135 C0856054
A499	UMLS-Preferred-Name E135 Mental status changes
A500	MEDDRA-PT E135 Mental status changes
A501	MEDDRA-PT-ID E135 10048294
A502	CUI E136 C0547030
A503	UMLS-Preferred-Name E136 Visual disturbance
A504	MEDDRA-PT E136 Visual impairment
A505	MEDDRA-PT-ID E136 10047571
A506	LLT E136 Visual disturbances
A507	LLT-ID E136 10047545
A508	CUI E137 C0036572
A509	UMLS-Preferred-Name E137 Seizures
A510	MEDDRA-PT E137 Seizure
A511	MEDDRA-PT-ID E137 10039906
A512	CUI E138 C3160858
A513	UMLS-Preferred-Name E138 Posterior reversible encephalopathy syndrome
A514	MEDDRA-PT E138 Posterior reversible encephalopathy syndrome
A515	MEDDRA-PT-ID E138 10071066
A516	CUI E139 C0948008
A517	UMLS-Preferred-Name E139 Ischemic stroke
A518	MEDDRA-PT E139 Ischaemic stroke
A519	MEDDRA-PT-ID E139 10061256
A520	LLT E139 Ischemic stroke
A521	LLT-ID E139 10055221
A522	CUI E140 C2937358
A523	UMLS-Preferred-Name E140 Cerebral Hemorrhage
A524	MEDDRA-PT E140 Cerebral haemorrhage
A525	MEDDRA-PT-ID E140 10008111
A526	LLT E140 Cerebral hemorrhage
A527	LLT-ID E140 10008114
A528	CUI E142 C0520837
A529	UMLS-Preferred-Name E142 Decreased forced expiratory volume
A530	MEDDRA-PT E142 Forced expiratory volume decreased
A531	MEDDRA-PT-ID E142 10016987
A532	CUI E143 C1697788
A533	UMLS-Preferred-Name E143 Carbon monoxide diffusing capacity decreased
A534	MEDDRA-PT E143 Carbon monoxide diffusing capacity decreased
A535	MEDDRA-PT-ID E143 10065906
A536	CUI E144 C0520837
A537	UMLS-Preferred-Name E144 Decreased forced expiratory volume
A538	MEDDRA-PT E144 Forced expiratory volume decreased
A539	MEDDRA-PT-ID E144 10016987
A540	LLT E144 FEV 1 decreased
A541	LLT-ID E144 10016550
A542	CUI E146 C1697788
A543	UMLS-Preferred-Name E146 Carbon monoxide diffusing capacity decreased
A544	MEDDRA-PT E146 Carbon monoxide diffusing capacity decreased
A545	MEDDRA-PT-ID E146 10065906
A546	CUI E145 C0860906
A547	UMLS-Preferred-Name E145 FEV 1 abnormal
A548	MEDDRA-PT E145 Forced expiratory volume abnormal
A549	MEDDRA-PT-ID E145 10016985
A550	CUI E148 C1697788
A551	UMLS-Preferred-Name E148 Carbon monoxide diffusing capacity decreased
A552	MEDDRA-PT E148 Carbon monoxide diffusing capacity decreased
A553	MEDDRA-PT-ID E148 10065906
A554	CUI E149 C0013404
A555	UMLS-Preferred-Name E149 Dyspnea
A556	MEDDRA-PT E149 Dyspnoea
A557	MEDDRA-PT-ID E149 10013968
A558	LLT E149 Dyspnea
A559	LLT-ID E149 10013963
A560	CUI E150 C0013404
A561	UMLS-Preferred-Name E150 Dyspnea
A562	MEDDRA-PT E150 Dyspnoea
A563	MEDDRA-PT-ID E150 10013968
A564	LLT E150 Dyspnea
A565	LLT-ID E150 10013963
A566	CUI E151 C0235996
A567	UMLS-Preferred-Name E151 Elevated liver enzymes
A568	MEDDRA-PT E151 Hepatic enzyme increased
A569	MEDDRA-PT-ID E151 10060795
A570	LLT E151 Elevated liver enzymes
A571	LLT-ID E151 10014481
A572	CUI E152 C2674385
A573	UMLS-Preferred-Name E152 Elevated liver transaminases
A574	MEDDRA-PT E152 Transaminases increased
A575	MEDDRA-PT-ID E152 10054889
A576	CUI E154 C2674385
A577	UMLS-Preferred-Name E154 Elevated liver transaminases
A578	MEDDRA-PT E154 Transaminases increased
A579	MEDDRA-PT-ID E154 10054889
A580	CUI E155 C0235996
A581	UMLS-Preferred-Name E155 Elevated liver enzymes
A582	MEDDRA-PT E155 Hepatic enzyme increased
A583	MEDDRA-PT-ID E155 10060795
A584	LLT E155 Elevated liver enzymes
A585	LLT-ID E155 10014481
A586	CUI E157 C0854268
A587	UMLS-Preferred-Name E157 Foetal damage
A588	MEDDRA-PT E157 Foetal damage
A589	MEDDRA-PT-ID E157 10016852
A590	LLT E157 Fetal damage
A591	LLT-ID E157 10054743
A592	CUI E158 C0277884
A593	UMLS-Preferred-Name E158 Increased systolic arterial pressure
A594	MEDDRA-PT E158 Blood pressure systolic increased
A595	MEDDRA-PT-ID E158 10005760
A596	CUI E160 C0277889
A597	UMLS-Preferred-Name E160 Increased diastolic arterial pressure
A598	MEDDRA-PT E160 Blood pressure diastolic increased
A599	MEDDRA-PT-ID E160 10005739
A600	CUI E162 C0020538
A601	UMLS-Preferred-Name E162 Hypertensive disease
A602	MEDDRA-PT E162 Hypertension
A603	MEDDRA-PT-ID E162 10020772
A604	CUI E163 C0853986
A605	UMLS-Preferred-Name E163 Lymphocyte count decreased
A606	MEDDRA-PT E163 Lymphocyte count decreased
A607	MEDDRA-PT-ID E163 10025256
A608	CUI E164 C1373218
A609	UMLS-Preferred-Name E164 Decreased Immunologic Activity [PE]
A610	MEDDRA-PT E164 Immunosuppression
A611	MEDDRA-PT-ID E164 10062016
A612	CUI E13 C0264907
A613	UMLS-Preferred-Name E13 Mobitz type I incomplete atrioventricular block
A614	MEDDRA-PT E13 Atrioventricular block second degree
A615	MEDDRA-PT-ID E13 10003677
A616	LLT E13 Mobitz type I
A617	LLT-ID E13 10027787
A618	CUI E14 C0264907
A619	UMLS-Preferred-Name E14 Mobitz type I incomplete atrioventricular block
A620	MEDDRA-PT E14 Atrioventricular block second degree
A621	MEDDRA-PT-ID E14 10003677
A622	LLT E14 Wenckebach phenomenon
A623	LLT-ID E14 10047909
A624	CUI E115 C1697788
A625	UMLS-Preferred-Name E115 Carbon monoxide diffusing capacity decreased
A626	MEDDRA-PT E115 Carbon monoxide diffusing capacity decreased
A627	MEDDRA-PT-ID E115 10065906
A628	CUI E116 C0520837
A629	UMLS-Preferred-Name E116 Decreased forced expiratory volume
A630	MEDDRA-PT E116 Forced expiratory volume decreased
A631	MEDDRA-PT-ID E116 10016987
A632	LLT E116 FEV 1 decreased
A633	LLT-ID E116 10016550
A634	CUI E39 C0855775
A635	UMLS-Preferred-Name E39 Pulmonary function test decreased
A636	MEDDRA-PT E39 Pulmonary function test decreased
A637	MEDDRA-PT-ID E39 10061922
A638	CUI E175 C0004245
A639	UMLS-Preferred-Name E175 Atrioventricular Block
A640	MEDDRA-PT E175 Atrioventricular block
A641	MEDDRA-PT-ID E175 10003671
A642	LLT E175 AV block
A643	LLT-ID E175 10003846
